Pfizer

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE182A01018
  • NSEID: PFIZER
  • BSEID: 500680
INR
4,822.80
23.75 (0.49%)
BSENSE

Jul 31, 03:30 PM

BSE+NSE Vol: 27.42 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Rubicon Research
Neuland Labs.
Granules India
Sai Life
Caplin Point Lab
Acutaas Chemical
OneSource Speci.
ERIS Lifescience
Pfizer
Piramal Pharma
Astrazeneca Phar

Why is Pfizer Ltd. ?

1
Poor long term growth as Net Sales has grown by an annual rate of 0.77% and Operating profit at 4.71% over the last 5 years
2
With ROE of 18.4, it has a Very Expensive valuation with a 5.3 Price to Book Value
  • The stock is trading at a fair value compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -7.76%, its profits have risen by 14.4% ; the PEG ratio of the company is 2
3
Below par performance in long term as well as near term
  • Along with generating -7.76% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Pfizer for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Pfizer
-7.76%
-0.31
24.67%
Sensex
-3.81%
-0.28
13.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0.77%
EBIT Growth (5y)
4.71%
EBIT to Interest (avg)
67.25
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.72
Sales to Capital Employed (avg)
0.70
Tax Ratio
25.95%
Dividend Payout Ratio
98.34%
Pledged Shares
0
Institutional Holding
19.45%
ROCE (avg)
51.90%
ROE (avg)
17.67%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
29
Industry P/E
37
Price to Book Value
5.25
EV to EBIT
21.53
EV to EBITDA
20.21
EV to Capital Employed
16.37
EV to Sales
7.41
PEG Ratio
1.99
Dividend Yield
1.55%
ROCE (Latest)
72.81%
ROE (Latest)
18.35%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 3,110.76 cr

DEBTORS TURNOVER RATIO(HY)

Highest at 13.86 times

NET SALES(Q)

Highest at Rs 653.17 cr

PBDIT(Q)

Highest at Rs 247.56 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 37.90%

PBT LESS OI(Q)

Highest at Rs 231.84 cr.

PAT(Q)

Highest at Rs 204.47 cr.

EPS(Q)

Highest at Rs 44.69

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Pfizer

Net Sales - Quarterly
Highest at Rs 653.17 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 247.56 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 37.90%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 231.84 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 204.47 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 44.69
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Cash and Cash Equivalents - Half Yearly
Highest at Rs 3,110.76 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio- Half Yearly
Highest at 13.86 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio